Is there a "best" choice of second-line agent in the treatment of recurrent, potentially platinum-sensitive ovarian cancer?

Source:http://linkedlifedata.com/resource/pubmed/id/11870154

J. Clin. Oncol. 2002 Mar 1 20 5 1158-60

Download in:

View as

General Info

PMID
11870154